High-Risk GEP Results Can Trigger SLNB and Imaging in Early Melanoma
Dr. Singh uses high-risk GEP scores to justify SLNB in stage I melanoma and imaging in node-negative stage II disease, where two-thirds of US melanoma deaths occur.
Topic
Topic
Dr. Singh uses high-risk GEP scores to justify SLNB in stage I melanoma and imaging in node-negative stage II disease, where two-thirds of US melanoma deaths occur.